Tech Company Financing Transactions
Protuoso Biosciences Funding Round
Protuoso Biosciences closed a $9.5 million Seed funding round on 5/27/2026. Investors included Darwin Ventures, Seeds Capital and private investors.
Transaction Overview
Company Name
Announced On
5/27/2026
Transaction Type
Venture Equity
Amount
$9,500,000
Round
Seed
Investors
Darwin Ventures (Lead Investor)
Proceeds Purpose
The company intends to use the funds to advance its multifunctional protein engineering platform and broad pipeline across cardiometabolic, oncology, and autoimmune diseases.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1030 Brittan Avenue
San Carlos, CA 94070
USA
San Carlos, CA 94070
USA
Phone
Undisclosed
Website
Email Address
Overview
Protuoso Bio combines advanced AI-driven protein engineering, computaional protein design, and synthetic biology to design differentiated, next-generation biologics for high-impact therapeutics. Our platform enables precise control of complex biology through modular and multifunctional architectures.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Tim Lu
Chief Medical Officer
Erik Heegaard
Chief Scientific Officer
Rick Austin
Chief Scientific Officer
Jim McGuire
Co-Founder
Willie Xiang
VP - Bus. Development
Joel Edwards
Browse more venture capital transactions:
Prev: 5/27/2026: Itera venture capital transaction
Next: 5/27/2026: Tensormesh venture capital transaction
Share this article
Where The Data Comes From
We do our best to document funding rounds that are announced publicly. VC investment data records on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs